The partnership between Crystec and Juniper Pharma Services has reached another key milestone, with Crystec’s commercial scale supercritical fluid rig now on-site at Juniper Pharma Services in Nottingham.
Crystec are delighted to have been shortlisted for the RSC Emerging Technologies Competition, which is focused on accelerating the commercialisation of innovative technologies. Crystec will pitch their novel treatment for urge incontinence to a panel of experts at Chemistry Means Business in Manchester 13th - 14th June 2017.
CrystecPharma awarded prestigious Newton Fund grant to tackle the increasing burden of COPD in China through the development of novel inhalable treatments
Crystec’s Development Director, Dr Lyn Daintree, will be speaking at a University of Leeds short course: Crystallisation Science and Engineering. The presentation will focus on ‘Supercritical Fluid Crystallisation'